How slashing £128m from 'low priority' NHS prescriptions will impact the pharmacy industry

  • Home
  • /
  • Podcasts
  • /
  • How slashing £128m from 'low priority' NHS prescriptions will impact the pharmacy industry - 29 Mar 17
Nigel Cassidy

How slashing £128m from 'low priority' NHS prescriptions will impact the pharmacy industry

Nigel Cassidy
Original Broadcast:

Share Radio Breakfast

How slashing £128m from 'low priority' NHS prescriptions will impact the pharmacy industry
The pharmacy industry is trying to assess the likely impact of a £128 million government move to stop GPs writing prescriptions for 'low-priority' items. You could soon be stopped from getting travel jabs, gluten-free foods and omega-3 supplements on the NHS. You may have heard it confirmed yesterday that 10 treatments are involved in the first round of the shake-up by NHS England chief executive Simon Stevens. What difference will this make? Galen Rosenberg, owner of the Maple Leaf Pharmacy spoke to Nigel Cassidy to discuss this further.
Guest:

Galen Rosenberg


Published:

Topics: UK (in Economics)

Strand: Share Radio Breakfast


Listen
View all podcasts